Herpes is not included in most standard STD panels. If you’ve been tested for STDs at a routine checkup, you were almost certainly screened for chlamydia, gonorrhea, syphilis, and HIV, but not for herpes simplex virus (HSV). This catches many people off guard, especially those who assumed a “full panel” meant everything.
Why Herpes Is Left Off Standard Panels
Standard STD screenings are designed around infections where early detection changes the outcome or prevents transmission through treatment. The typical panel covers chlamydia, gonorrhea, syphilis, and HIV. Pregnant people are also screened for hepatitis B. Herpes falls into a different category for several reasons.
The blood tests available for herpes have a meaningful false positive rate, particularly in people with a low risk of infection or those tested too soon after potential exposure. The FDA has specifically warned that results near the cutoff threshold (sometimes called “low positives”) are unreliable. For someone without symptoms and no known exposure, a false positive result can cause significant psychological harm with no clear medical benefit. Because herpes is extremely common and often causes no symptoms at all, screening the general population would generate a large number of ambiguous or incorrect results.
There is one notable exception: people living with HIV are typically recommended to be screened for herpes along with syphilis and gonorrhea, because co-infection can complicate both conditions.
What Tests Actually Detect Herpes
There are two main approaches to herpes testing, and each works best in different situations.
Swab tests are used when you have an active sore or blister. A clinician swabs the lesion directly and sends it to a lab. The most accurate version uses PCR (polymerase chain reaction) technology, which detects the virus’s genetic material. PCR picks up roughly 86% of true infections, compared to about 43% for the older viral culture method. Both methods are highly specific, meaning a positive result is almost certainly correct. But swab tests only work while a sore is present and producing virus, so timing matters. If a sore has already started healing, the test becomes less reliable.
Blood tests look for antibodies your immune system produces in response to the virus. These are type-specific IgG tests that can distinguish between HSV-1 (the type most associated with oral herpes) and HSV-2 (more commonly linked to genital herpes). The key limitation is timing: after exposure, it can take up to 16 weeks or longer for antibodies to reach detectable levels. Testing too early is one of the main reasons for inaccurate results.
HSV-1 Blood Tests Are Especially Tricky
Even when you do get a blood test, interpreting HSV-1 results is complicated. HSV-1 is so widespread in the general population that a positive antibody result tells you very little. It could reflect a childhood oral infection from decades ago, or it could indicate a more recent genital infection. The blood test can’t tell you where on your body the virus lives. Researchers have found that antibody testing for HSV-1 has relatively low diagnostic accuracy for genital herpes specifically, because so many people carry HSV-1 antibodies regardless of genital involvement.
HSV-2 antibody results are more clinically useful since HSV-2 is strongly associated with genital infection. Still, low-positive results (scores just above the cutoff) should be interpreted cautiously and may need confirmatory testing.
How to Get Tested If You Want It
If you want herpes included in your STD screening, you need to ask for it explicitly. Simply requesting a “full STD panel” or “test me for everything” will not automatically include herpes at most clinics and labs. Ask specifically for a type-specific HSV IgG blood test. This is the version that differentiates between HSV-1 and HSV-2, which matters because the two types have different patterns of recurrence and transmission.
If you have an active sore, request a PCR swab test of the lesion rather than relying on a blood test alone. A swab during an active outbreak gives the most definitive answer. If you’re getting a blood test without symptoms, make sure at least 16 weeks have passed since the potential exposure you’re concerned about. Testing before that window closes increases the chance of a false negative.
What Your Results Mean in Practice
A positive swab test from an active lesion is highly reliable. If the lab used PCR and identified HSV-1 or HSV-2, you can trust that result.
A positive blood test is more nuanced. A clearly elevated IgG level for HSV-2 in someone with risk factors is a strong indicator. A low-positive result, especially in someone with no symptoms and no known exposure, may warrant a second confirmatory test. The FDA has flagged this specific scenario as prone to false positives.
A negative blood test taken within the first few months after exposure doesn’t rule anything out. Your body may not have produced enough antibodies yet. If you had a specific exposure that concerns you, retesting after the full 16-week window gives a more accurate picture.
Avoid IgM-based herpes tests if they’re offered. These tests look for a different type of antibody that appears early in any immune response and can cross-react with other infections. They cannot reliably distinguish between a new herpes infection and other conditions, and most sexual health experts consider them unhelpful for herpes diagnosis.